Paul M. Palz

Horizon Pharma, Inc. discovers and develops medicines for the treatment of chronic inflammatory diseases. It is a specialty pharmaceutical company that has developed and is commercializing DUEXIS and RAYOS, both of which target unmet therapeutic needs in arthritis, pain and inflammatory diseases. The company products include DUEXIS (ibuprofen and famotidine) Tablets, is a proprietary, single-tablet combination of the non-steroidal anti-inflammatory drug ibuprofen and the histamine H2-receptor antagonist famotidine; RAYOS (prednisone) delayed-release tablets, known as LODOTRA outside the U.S., is a proprietary delayed-release formulation of low-dose prednisone for the treatment of moderate to severe, active RA in adults, particularly when accompanied by morning stiffness. Horizon Pharma was founded on March 23, 2010 and is headquartered in Deerfield, IL.

Adello Biologics LLC develops and supplies biosimilar recombinant therapeutic proteins. It also offers antibody products for major regulated markets and strategic markets globally. The company was founded by Sarfaraz K. Niazi and is headquartered in Piscataway, NJ.

Arthur Andersen LLP used to provide accounting services. It was also into consulting services for clients that operate businesses throughout the United States and around the world. Arthur Andersen was founded in 1913 and was headquartered in Chicago, IL.

DGT Holdings Corp. engages in the development, manufacture and market of medical imaging equipment, power conversion subsystems and components worldwide. The company was founded on October 25, 1954 and is headquartered in New York, NY.